Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:52 UTC |
---|
Update Date | 2022-03-07 02:51:58 UTC |
---|
HMDB ID | HMDB0015386 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Retapamulin |
---|
Description | Retapamulin, also known as SB 275833 or altabax, belongs to the class of organic compounds known as pleuromutilin and derivatives. These are mutilins with a hydroxyacetate derivative attached to the C8 carbon atom of the cyclopenta[8]annulene moiety. Based on a literature review a significant number of articles have been published on Retapamulin. |
---|
Structure | C[C@@H]1CC[C@@]23CCC(=O)[C@H]2[C@]1(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]3C)OC(=O)CSC1C[C@@H]2CC[C@H](C1)N2C InChI=1S/C30H47NO4S/c1-7-28(4)16-24(35-25(33)17-36-22-14-20-8-9-21(15-22)31(20)6)29(5)18(2)10-12-30(19(3)27(28)34)13-11-23(32)26(29)30/h7,18-22,24,26-27,34H,1,8-17H2,2-6H3/t18-,19+,20-,21+,22?,24-,26+,27+,28-,29+,30+/m1/s1 |
---|
Synonyms | Value | Source |
---|
SB 275833 | HMDB | Altabax | HMDB | (1S,2R,3S,4S,6R,7R,8R,14R)-4-Ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxotricyclo[5.4.3.0¹,⁸]tetradecan-6-yl 2-{[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]sulfanyl}acetic acid | HMDB | (1S,2R,3S,4S,6R,7R,8R,14R)-4-Ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxotricyclo[5.4.3.0¹,⁸]tetradecan-6-yl 2-{[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]sulphanyl}acetate | HMDB | (1S,2R,3S,4S,6R,7R,8R,14R)-4-Ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxotricyclo[5.4.3.0¹,⁸]tetradecan-6-yl 2-{[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]sulphanyl}acetic acid | HMDB | (1S,2R,3S,4S,6R,7R,8R,14R)-4-Ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxotricyclo[5.4.3.0,]tetradecan-6-yl 2-{[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]sulfanyl}acetic acid | HMDB | (1S,2R,3S,4S,6R,7R,8R,14R)-4-Ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxotricyclo[5.4.3.0,]tetradecan-6-yl 2-{[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]sulphanyl}acetate | HMDB | (1S,2R,3S,4S,6R,7R,8R,14R)-4-Ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxotricyclo[5.4.3.0,]tetradecan-6-yl 2-{[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]sulphanyl}acetic acid | HMDB | Retapamulin | MeSH |
|
---|
Chemical Formula | C30H47NO4S |
---|
Average Molecular Weight | 517.763 |
---|
Monoisotopic Molecular Weight | 517.322579687 |
---|
IUPAC Name | (1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxotricyclo[5.4.3.0¹,⁸]tetradecan-6-yl 2-{[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]sulfanyl}acetate |
---|
Traditional Name | retapamulin |
---|
CAS Registry Number | 224452-66-8 |
---|
SMILES | C[C@@H]1CC[C@@]23CCC(=O)[C@H]2[C@]1(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]3C)OC(=O)CSC1C[C@@H]2CC[C@H](C1)N2C |
---|
InChI Identifier | InChI=1S/C30H47NO4S/c1-7-28(4)16-24(35-25(33)17-36-22-14-20-8-9-21(15-22)31(20)6)29(5)18(2)10-12-30(19(3)27(28)34)13-11-23(32)26(29)30/h7,18-22,24,26-27,34H,1,8-17H2,2-6H3/t18-,19+,20-,21+,22?,24-,26+,27+,28-,29+,30+/m1/s1 |
---|
InChI Key | STZYTFJPGGDRJD-FJJJPKKESA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as pleuromutilin and derivatives. These are mutilins with a hydroxyacetate derivative attached to the C8 carbon atom of the cyclopenta[8]annulene moiety. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Prenol lipids |
---|
Sub Class | Diterpenoids |
---|
Direct Parent | Pleuromutilin and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Pleuromutilin
- Tropane alkaloid
- Piperidine
- N-alkylpyrrolidine
- Pyrrolidine
- Amino acid or derivatives
- Carboxylic acid ester
- Ketone
- Secondary alcohol
- Tertiary amine
- Tertiary aliphatic amine
- Carboxylic acid derivative
- Thioether
- Azacycle
- Organoheterocyclic compound
- Dialkylthioether
- Sulfenyl compound
- Monocarboxylic acid or derivatives
- Carbonyl group
- Organosulfur compound
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Amine
- Organic oxide
- Organic oxygen compound
- Hydrocarbon derivative
- Organopnictogen compound
- Alcohol
- Aliphatic heteropolycyclic compound
|
---|
Molecular Framework | Aliphatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.00039 g/L | Not Available | LogP | 5 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Retapamulin,1TMS,isomer #1 | C=C[C@]1(C)C[C@@H](OC(=O)CSC2C[C@@H]3CC[C@H](C2)N3C)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O[Si](C)(C)C | 3769.6 | Semi standard non polar | 33892256 | Retapamulin,1TMS,isomer #2 | C=C[C@]1(C)C[C@@H](OC(=O)CSC2C[C@@H]3CC[C@H](C2)N3C)[C@@]2(C)C3=C(O[Si](C)(C)C)CC[C@@]3(CC[C@H]2C)[C@@H](C)[C@@H]1O | 3645.2 | Semi standard non polar | 33892256 | Retapamulin,1TMS,isomer #3 | C=C[C@]1(C)C[C@@H](OC(=O)CSC2C[C@@H]3CC[C@H](C2)N3C)[C@]2(C)[C@H](C)CC[C@]3(CC=C(O[Si](C)(C)C)[C@H]32)[C@@H](C)[C@@H]1O | 3779.8 | Semi standard non polar | 33892256 | Retapamulin,2TMS,isomer #1 | C=C[C@]1(C)C[C@@H](OC(=O)CSC2C[C@@H]3CC[C@H](C2)N3C)[C@@]2(C)C3=C(O[Si](C)(C)C)CC[C@@]3(CC[C@H]2C)[C@@H](C)[C@@H]1O[Si](C)(C)C | 3617.1 | Semi standard non polar | 33892256 | Retapamulin,2TMS,isomer #1 | C=C[C@]1(C)C[C@@H](OC(=O)CSC2C[C@@H]3CC[C@H](C2)N3C)[C@@]2(C)C3=C(O[Si](C)(C)C)CC[C@@]3(CC[C@H]2C)[C@@H](C)[C@@H]1O[Si](C)(C)C | 3628.9 | Standard non polar | 33892256 | Retapamulin,2TMS,isomer #1 | C=C[C@]1(C)C[C@@H](OC(=O)CSC2C[C@@H]3CC[C@H](C2)N3C)[C@@]2(C)C3=C(O[Si](C)(C)C)CC[C@@]3(CC[C@H]2C)[C@@H](C)[C@@H]1O[Si](C)(C)C | 4331.4 | Standard polar | 33892256 | Retapamulin,2TMS,isomer #2 | C=C[C@]1(C)C[C@@H](OC(=O)CSC2C[C@@H]3CC[C@H](C2)N3C)[C@]2(C)[C@H](C)CC[C@]3(CC=C(O[Si](C)(C)C)[C@H]32)[C@@H](C)[C@@H]1O[Si](C)(C)C | 3730.8 | Semi standard non polar | 33892256 | Retapamulin,2TMS,isomer #2 | C=C[C@]1(C)C[C@@H](OC(=O)CSC2C[C@@H]3CC[C@H](C2)N3C)[C@]2(C)[C@H](C)CC[C@]3(CC=C(O[Si](C)(C)C)[C@H]32)[C@@H](C)[C@@H]1O[Si](C)(C)C | 3520.5 | Standard non polar | 33892256 | Retapamulin,2TMS,isomer #2 | C=C[C@]1(C)C[C@@H](OC(=O)CSC2C[C@@H]3CC[C@H](C2)N3C)[C@]2(C)[C@H](C)CC[C@]3(CC=C(O[Si](C)(C)C)[C@H]32)[C@@H](C)[C@@H]1O[Si](C)(C)C | 4281.7 | Standard polar | 33892256 | Retapamulin,1TBDMS,isomer #1 | C=C[C@]1(C)C[C@@H](OC(=O)CSC2C[C@@H]3CC[C@H](C2)N3C)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O[Si](C)(C)C(C)(C)C | 3994.2 | Semi standard non polar | 33892256 | Retapamulin,1TBDMS,isomer #2 | C=C[C@]1(C)C[C@@H](OC(=O)CSC2C[C@@H]3CC[C@H](C2)N3C)[C@@]2(C)C3=C(O[Si](C)(C)C(C)(C)C)CC[C@@]3(CC[C@H]2C)[C@@H](C)[C@@H]1O | 3877.2 | Semi standard non polar | 33892256 | Retapamulin,1TBDMS,isomer #3 | C=C[C@]1(C)C[C@@H](OC(=O)CSC2C[C@@H]3CC[C@H](C2)N3C)[C@]2(C)[C@H](C)CC[C@]3(CC=C(O[Si](C)(C)C(C)(C)C)[C@H]32)[C@@H](C)[C@@H]1O | 3990.9 | Semi standard non polar | 33892256 | Retapamulin,2TBDMS,isomer #1 | C=C[C@]1(C)C[C@@H](OC(=O)CSC2C[C@@H]3CC[C@H](C2)N3C)[C@@]2(C)C3=C(O[Si](C)(C)C(C)(C)C)CC[C@@]3(CC[C@H]2C)[C@@H](C)[C@@H]1O[Si](C)(C)C(C)(C)C | 4054.4 | Semi standard non polar | 33892256 | Retapamulin,2TBDMS,isomer #1 | C=C[C@]1(C)C[C@@H](OC(=O)CSC2C[C@@H]3CC[C@H](C2)N3C)[C@@]2(C)C3=C(O[Si](C)(C)C(C)(C)C)CC[C@@]3(CC[C@H]2C)[C@@H](C)[C@@H]1O[Si](C)(C)C(C)(C)C | 4062.1 | Standard non polar | 33892256 | Retapamulin,2TBDMS,isomer #1 | C=C[C@]1(C)C[C@@H](OC(=O)CSC2C[C@@H]3CC[C@H](C2)N3C)[C@@]2(C)C3=C(O[Si](C)(C)C(C)(C)C)CC[C@@]3(CC[C@H]2C)[C@@H](C)[C@@H]1O[Si](C)(C)C(C)(C)C | 4509.4 | Standard polar | 33892256 | Retapamulin,2TBDMS,isomer #2 | C=C[C@]1(C)C[C@@H](OC(=O)CSC2C[C@@H]3CC[C@H](C2)N3C)[C@]2(C)[C@H](C)CC[C@]3(CC=C(O[Si](C)(C)C(C)(C)C)[C@H]32)[C@@H](C)[C@@H]1O[Si](C)(C)C(C)(C)C | 4153.8 | Semi standard non polar | 33892256 | Retapamulin,2TBDMS,isomer #2 | C=C[C@]1(C)C[C@@H](OC(=O)CSC2C[C@@H]3CC[C@H](C2)N3C)[C@]2(C)[C@H](C)CC[C@]3(CC=C(O[Si](C)(C)C(C)(C)C)[C@H]32)[C@@H](C)[C@@H]1O[Si](C)(C)C(C)(C)C | 3830.1 | Standard non polar | 33892256 | Retapamulin,2TBDMS,isomer #2 | C=C[C@]1(C)C[C@@H](OC(=O)CSC2C[C@@H]3CC[C@H](C2)N3C)[C@]2(C)[C@H](C)CC[C@]3(CC=C(O[Si](C)(C)C(C)(C)C)[C@H]32)[C@@H](C)[C@@H]1O[Si](C)(C)C(C)(C)C | 4448.6 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Retapamulin GC-MS (Non-derivatized) - 70eV, Positive | splash10-0kmi-9711120000-fcdfffe2635f8f75be04 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Retapamulin GC-MS (1 TMS) - 70eV, Positive | splash10-00di-9551060000-42bdf7a4a7e4a697f8d3 | 2017-10-06 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Retapamulin 10V, Positive-QTOF | splash10-1000-0912070000-67b87f331f6188105b85 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Retapamulin 20V, Positive-QTOF | splash10-0udj-7948240000-c7e591627af7f54b3685 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Retapamulin 40V, Positive-QTOF | splash10-0a4l-4900000000-e32d32923adfee80b8d1 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Retapamulin 10V, Negative-QTOF | splash10-014i-0709150000-8b404ff35785559f3a6c | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Retapamulin 20V, Negative-QTOF | splash10-0600-0905010000-eb22b08bf5106978dbe9 | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Retapamulin 40V, Negative-QTOF | splash10-00xr-9737000000-0c83dbfb5064e95dbe86 | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Retapamulin 10V, Positive-QTOF | splash10-0gb9-0312190000-34064f2cad0ea14ddea8 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Retapamulin 20V, Positive-QTOF | splash10-0gi1-0920440000-c27556e56d29a64cf689 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Retapamulin 40V, Positive-QTOF | splash10-00di-4900000000-49114c3baf9b395b57fa | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Retapamulin 10V, Negative-QTOF | splash10-066r-1005090000-f70e4d716b40fb2a11ca | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Retapamulin 20V, Negative-QTOF | splash10-06di-7900170000-e86bae12bb724e8a2917 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Retapamulin 40V, Negative-QTOF | splash10-0udj-5921120000-62814e58892726823fd7 | 2021-10-11 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB01256 | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB01256 | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 5293659 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Retapamulin |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 6918462 |
---|
PDB ID | Not Available |
---|
ChEBI ID | Not Available |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Jones RN, Fritsche TR, Sader HS, Ross JE: Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant gram-positive cocci. Antimicrob Agents Chemother. 2006 Jul;50(7):2583-6. [PubMed:16801451 ]
- Jacobs MR: Retapamulin: a semisynthetic pleuromutilin compound for topical treatment of skin infections in adults and children. Future Microbiol. 2007 Dec;2(6):591-600. [PubMed:18041900 ]
- Parish LC, Parish JL: Retapamulin: a new topical antibiotic for the treatment of uncomplicated skin infections. Drugs Today (Barc). 2008 Feb;44(2):91-102. doi: 10.1358/dot.2008.44.2.1153446. [PubMed:18389088 ]
- Yang LP, Keam SJ: Retapamulin: a review of its use in the management of impetigo and other uncomplicated superficial skin infections. Drugs. 2008;68(6):855-73. [PubMed:18416589 ]
- Authors unspecified: Retapamulin for impetigo and other infections. Drug Ther Bull. 2008 Oct;46(10):76-9. doi: 10.1136/dtb.2008.09.0023. [PubMed:18832258 ]
- Shawar R, Scangarella-Oman N, Dalessandro M, Breton J, Twynholm M, Li G, Garges H: Topical retapamulin in the management of infected traumatic skin lesions. Ther Clin Risk Manag. 2009 Feb;5(1):41-9. Epub 2009 Mar 26. [PubMed:19436611 ]
- Nagabushan H: Retapamulin: a novel topical antibiotic. Indian J Dermatol Venereol Leprol. 2010 Jan-Feb;76(1):77-9. doi: 10.4103/0378-6323.58693. [PubMed:20061745 ]
- Novak R, Shlaes DM: The pleuromutilin antibiotics: a new class for human use. Curr Opin Investig Drugs. 2010 Feb;11(2):182-91. [PubMed:20112168 ]
- Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9. [PubMed:11413487 ]
- Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10. [PubMed:16902246 ]
- Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20. [PubMed:17374880 ]
- Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621. [PubMed:20044567 ]
- Gunstone, Frank D., John L. Harwood, and Albert J. Dijkstra (2007). The lipid handbook with CD-ROM. CRC Press.
- CenterWatch [Link]
|
---|